If two “End the Pill Penalty” flyers have reached my dusty rural mailbox, chances are many Minnesotans have received these Big Pharma-friendly missives, too. The flyers almost got tossed with ...

These undatable men are those who subscribe to the “red pill” notion, an alarming subculture that perpetuates a societal hatred against women by opposing feminist narratives and emphasizing ...

The jab averse can now rejoice! Drug manufacturer Eli Lilly announced this week that an encouraging clinical trial of their new pill promises a convenient, stab-free way to treat diabetes and obesity.

A new pill designed to help with weight loss and blood sugar control is showing promise in early studies. Eli Lilly said its experimental drug, orforglipron, helped people with Type 2 diabetes ...

Drugmaker Eli Lilly announced promising Phase 3 study results for its new GLP-1 pill. Orforglipron is a drug similar to Ozempic but without the injection, making it more accessible. The pill ...

Now, a GLP-1 in pill form is showing promising results for weight loss and blood sugar control — no needles required. The medication — orforglipron from pharmaceutical giant Eli Lilly — is ...

But JBL is no longer alone. When Beats revived its fan-favorite Pill speaker in 2024, it did so at a more accesible price and added some great new features. The similarites between these Bluetooth ...

A new GLP-1 pill from Eli Lilly has shown positive results in clinical trials. New research released Thursday morning shows a new, oral GLP-1 pill may be just as beneficial to those with Type 2 ...

Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable drugs. By Gina Kolata and Rebecca Robbins A daily pill may be as ...

A business plan emerged, and now, more than a decade and two startups later, Emerson is selling millions of pot pills a year in seven states. If pot pills sound like an oxymoron, it’s only ...

The anti-aging pill still needs to earn a safety and manufacturing certification by the FDA in order to by approved Kimberlee Speakman is a digital writer at PEOPLE. She has been working at PEOPLE ...